Abstract
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have